In this first installment of the “Navigating the MedTech Start-Up World” podcast, Sheri Krajewski-Bibins (NAMSA’s Product Marketing Manager – Biological Safety and the host of NAMSA’s “BiocomCHATibility” podcast) co-hosts alongside Duane Mancini (NAMSA’s MRO Strategy Advisor) to help introduce our brand new podcast series.
“You help customers understand how to use NAMSA services from beginning to end to shorten timelines and get to market faster.” – Sheri Krajewski-Bibins
“Coaching start-ups to have a holistic approach from the beginning, including regulatory, reimbursement and clinical. If you aren’t thinking about these three from the beginning, you can get into a lot of trouble later on.” -Duane Mancini
“A place to go for start-up companies where they can listen to people who have done this successfully, industry experts and people who are funding them.” – Duane Mancini
Also be sure to check out our MRO Program Opportunities.
|Sheri Krajewski-Bibins; Product Marketing Manager – Biological Safety, NAMSA
Sheri joined NAMSA in 2003 and currently serves as Global Product Marketing Manager of Biological Safety. She has supported customers in a variety of commercial operations and management roles, and was an integral leader in the development of NAMSA’s biological safety consulting business. Additionally, Sheri created the much sought-after NAMSA Training Series for the biological evaluation of medical devices. Prior to NAMSA, Sheri was the marketing lead for a mechanical fatigue laboratory and consulting business where she worked primarily with cardiovascular implant manufacturers. Sheri holds a Bachelor’s Degree from the University of Nebraska.
|Duane Mancini; MRO Strategy Advisor, NAMSA
Duane Mancini, M. Sc. is an MRO Strategy Advisor, specializing in applying NAMSA’s end to end services for medical device companies. He holds a Master of Science in Medicinal Chemistry and a Bachelor’s of Science in Pharmaceutical Sciences, both from the University of Toledo. During his career at NAMSA, he has supported several projects in commercialization strategy and biological safety strategy, as well as regulatory strategy, support and quality. He is an active member in the American Chemical Society (ACS).